NCT07793474Not yet recruiting
Eye Patient Adherence and Compliance Study
Eye Patient Adherence and Compliance Study-Intervention Program (EYE-PACIP): Improving Glaucoma Adherence and Compliance in High-risk Patients With a Multi-interventional Program
Source: ClinicalTrials.gov · Last updated 28 Aug 2026
Brief summary (registry, in English)
This study looks at ways to help people with glaucoma take their eye drops regularly and attend their clinic appointments. Each participant will be asked about the main challenges they face, such as forgetfulness, difficulty using drops, lack of transportation, or limited understanding of their condition. Based on their biggest challenge, participants will receive one type of support that is already part of usual care, such as education, reminders, help with applying drops, or assistance getting to appointments. The investigators will follow participants over time to see if this support improves how well they follow their treatment and their quality of life.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 189 (estimated)
- First submitted
- 4 May 2026
- Start date
- Sept 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- St. Joseph's Healthcare Hamilton
- Diseases
- Glaucoma
- NCT number
- NCT07793474
What you commit to
- Study type: Interventional
- Planned participants: 189
- From Sept 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Significant cognitive impairment, neurodegenerative disease, or severe psychiatric illness limiting participation or understanding of the intervention
Other
- Participants will be excluded if they meet any of the following criteria:
- Participation in another interventional study targeting glaucoma adherence or follow-up
- Anticipated inability to complete 12-month follow-up (e.g., planned relocation or transfer of care outside the study catchment area)
Criteria the registry did not label
- Participants will be eligible for inclusion if they meet all of the following criteria:
- Adults aged 18 years and older
- Clinical diagnosis of glaucoma or ocular hypertension confirmed by an ophthalmologist
- Currently prescribed at least one topical intraocular pressure (IOP)-lowering medication
- Identified as high risk for non-adherence and/or poor follow-up, defined by one or more of the following:
- Self-reported or documented missed ≥20% of prescribed eye drops
- Missed two or more glaucoma clinic appointments
- Evidence of structural or functional glaucoma progression (e.g., OCT or visual field deterioration)
- Willing to participate in study interventions and follow-up assessments Able to communicate in the study language.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St Joseph's Regional Eye Clinic Coordinator of this site? Confirm its status | Hamilton | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.